The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ABBVIE INC | COM | 00287Y109 | 87,273 | 1,298,900 | SH | SOLE | 1,298,900 | 0 | 0 | ||
| ADMA BIOLOGICS INC | COM | 000899104 | 9,582 | 1,034,721 | SH | SOLE | 1,034,721 | 0 | 0 | ||
| AKORN INC | COM | 009728106 | 80,498 | 1,843,756 | SH | SOLE | 1,843,756 | 0 | 0 | ||
| ANI PHARMACEUTICALS INC | COM | 00182C103 | 65,512 | 1,055,791 | SH | SOLE | 1,055,791 | 0 | 0 | ||
| BIOLASE INC | COM | 090911108 | 1,162 | 667,664 | SH | SOLE | 667,664 | 0 | 0 | ||
| BIOTIME INC | COM | 09066L105 | 2,380 | 655,540 | SH | SOLE | 655,540 | 0 | 0 | ||
| CARDIOVASCULAR SYS INC DEL | COM | 141619106 | 65,498 | 2,476,287 | SH | SOLE | 2,476,287 | 0 | 0 | ||
| CATALYST PHARMACEUTICALS INC | COM | 14888U101 | 22,789 | 5,517,885 | SH | SOLE | 5,517,885 | 0 | 0 | ||
| CELLDEX THERAPEUTICS INC NEW | COM | 15117B103 | 18,959 | 751,748 | SH | SOLE | 751,748 | 0 | 0 | ||
| CLOVIS ONCOLOGY INC | COM | 189464100 | 26,639 | 303,131 | SH | SOLE | 303,131 | 0 | 0 | ||
| DERMA SCIENCES INC | COM PAR $.01 | 249827502 | 12,606 | 1,760,649 | SH | SOLE | 1,760,649 | 0 | 0 | ||
| EAGLE PHARMACEUTICALS INC | COM | 269796108 | 95,690 | 1,183,406 | SH | SOLE | 1,183,406 | 0 | 0 | ||
| EHEALTH INC | COM | 28238P109 | 67 | 5,242 | SH | SOLE | 5,242 | 0 | 0 | ||
| ENANTA PHARMACEUTICALS INC | COM | 29251M106 | 55,847 | 1,241,321 | SH | SOLE | 1,241,321 | 0 | 0 | ||
| EPIRUS BIOPHARMACEUTICALS IN | COM | 29428P107 | 12,939 | 2,265,988 | SH | SOLE | 2,265,988 | 0 | 0 | ||
| HEALTHWAYS INC | COM | 422245100 | 12,100 | 1,010,025 | SH | SOLE | 1,010,025 | 0 | 0 | ||
| IMPRIVATA INC | COM | 45323J103 | 1,567 | 95,759 | SH | SOLE | 95,759 | 0 | 0 | ||
| INSYS THERAPEUTICS INC NEW | COM NEW | 45824V209 | 107,189 | 2,984,094 | SH | SOLE | 2,984,094 | 0 | 0 | ||
| MERUS LABS INTL INC NEW | COM | 59047R101 | 3,825 | 1,641,588 | SH | SOLE | 1,641,588 | 0 | 0 | ||
| NANOSTRING TECHNOLOGIES INC | COM | 63009R109 | 6,929 | 449,325 | SH | SOLE | 449,325 | 0 | 0 | ||
| ORTHOFIX INTL N V | COM | N6748L102 | 57,155 | 1,725,697 | SH | SOLE | 1,725,697 | 0 | 0 | ||
| OSIRIS THERAPEUTICS INC NEW | COM | 68827R108 | 22,889 | 1,176,195 | SH | SOLE | 1,176,195 | 0 | 0 | ||
| PACIFIC BIOSCIENCES CALIF IN | COM | 69404D108 | 31,097 | 5,398,861 | SH | SOLE | 5,398,861 | 0 | 0 | ||
| RETROPHIN INC | COM | 761299106 | 112,721 | 3,400,323 | SH | SOLE | 3,400,323 | 0 | 0 | ||
| SIENTRA INC | COM | 82621J105 | 3,334 | 132,135 | SH | SOLE | 132,135 | 0 | 0 | ||
| UNITED THERAPEUTICS CORP DEL | COM | 91307C102 | 67,351 | 387,186 | SH | SOLE | 387,186 | 0 | 0 | ||
| VERACYTE INC | COM | 92337F107 | 8,400 | 2,352,940 | SH | SOLE | 2,352,940 | 0 | 0 | ||
| VERICEL CORP | COM | 92346J108 | 3,330 | 298,966 | SH | SOLE | 298,966 | 0 | 0 | ||